Mark Akeson, Santa Cruz, USA DNA analysis using Nanopores Francois Bernier, Calgary, Canada TBA Kym Boycott, Ottawa, Canada TBA Thomas Caskey, TX, USA The future of Genomics Richard G.H. Cotton, Melbourne, Australia The Human Variome Project Johan T. den Dunnen, Leiden, The Netherlands New seq. technologies and their application in medical research Marc Greenblatt, VT, USA Classification of variants Stefan Harrer, Melbourne, Australia DNA Nanopore Seq. Steven Jones, Vancouver, Canada Whole genome seq. Stephen Kingsmore, Kansas City, USA Experience with targeted panels, exomes and genomes for timely diagnosis of genetic diseases in a children's hospital Jacek Majewski, Montreal, Canada Exome and Whole-Exome Seq. for gene disovery Yves Moreau, Leuven, Belgium Microarray analysis of CNV in single cells; exome CNV Mats Nilsson, Stockholm, Sweden In situ seq. for mutation detection directly in tumor tissue sections Graham Taylor, Leeds, UK Quality control of mutation detection by next generation seq. Ciska Wijmenga, Groningen, The Netherlands Genome of the Netherlands Liz Worthey, Wisconsin, USA Making a Definitive Diagnosis: Experiences from our WGS based Genomic Medicine Clinic Sunney Xie, Cambridge, MA, USA Single Cell Whole Genome Amplification and Sequencing: Direct Measurements of Human Mutation Rate
|